Dutch Dementia Research Conference 2027

11 February 2027 | All day | 1931 Conference Centre | ‘s-Hertogenbosch

Around 400 dementia researchers, international guests and other interested parties attended the 2026 Dutch Dementia Research Conference. We expect significant participation from both within and outside the dementia research community in 2027 as well.

• Abstract submission is open until November 2, 2026
• Registration opens on November 4, 2026

Keynote speaker: Catherine Mummery

World-renowned scientist Prof. Dr Catherine Mummery is one of the keynote speakers at the DDRC!

Mummery chairs the Dementia Translational Research Collaboration and directs the Dementia Trials Network (both within the National Institute for Health and Care Research, NIHR). Through these roles, she is building a national, integrated network for early-stage clinical trials and working to accelerate and improve translational research into new dementia treatments.

In addition, Mummery is Head of Clinical Research at the Dementia Research Centre, University College London (UCL). She has served as principal investigator on more than twenty early-stage clinical trials investigating potential therapies for rare and genetic forms of Alzheimer’s disease and frontotemporal dementia. As the clinical lead for the UCL Neurogenetic Therapies Programme, she heads an innovative industry-academia partnership aimed at accelerating progress in genetic therapies for dementia.

About DDRC

During this one-day conference in ’s-Hertogenbosch (1931.nl), the full spectrum of Dutch dementia research will be covered, ranging from fundamental to applied research in healthcare and wellbeing, whilst also highlighting emerging themes such as technology and business. You will have the opportunity to meet most Dutch dementia researchers, international guests and key representatives from the private sector.

Every edition of the DDRC features various parallel sessions, poster presentations and engaging speakers. There are ample opportunities to get to know one another and learn about implementation, best practices and target-group participation. At this conference, we collectively make a significant contribution to the implementation of dementia research.